Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Biostocks01on Apr 10, 2019 3:56pm
265 Views
Post# 29609087

RE:RE:RE:Conversion/new equity raise price 15 cents

RE:RE:RE:Conversion/new equity raise price 15 centsSah1,

the conversion price should be based on a predictable cash flow discounting model...according to the calculations of the RBC, it is .70$.

the cash flow remains reliable since it is representative of inflows of funds of all kinds including strategic transactions.

if the conversation is made at a price approximating the intrinsic value...the market reaction will be positive.


Bio



Bullboard Posts